赛诺医疗
(688108)
| 流通市值：85.00亿 | | | 总市值：85.00亿 |
| 流通股本：4.16亿 | | | 总股本：4.16亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 363,854,525.58 | 240,476,013.66 | 100,849,103.23 | 458,739,271.36 |
| 营业收入 | 363,854,525.58 | 240,476,013.66 | 100,849,103.23 | 458,739,271.36 |
| 二、营业总成本 | 348,935,582.94 | 234,401,263.96 | 106,844,000.33 | 490,838,082.21 |
| 营业成本 | 124,786,396.64 | 87,427,710.14 | 40,680,235.11 | 174,587,205.02 |
| 税金及附加 | 4,203,503.8 | 2,866,304.24 | 1,202,230.15 | 3,645,204.88 |
| 销售费用 | 54,589,299.32 | 35,499,042.15 | 15,103,424.6 | 78,953,775.78 |
| 管理费用 | 69,380,991.61 | 46,927,417.69 | 22,321,712.5 | 89,493,215.42 |
| 研发费用 | 92,757,264.16 | 59,707,969.51 | 26,583,284.27 | 140,557,411.47 |
| 财务费用 | 3,218,127.41 | 1,972,820.23 | 953,113.7 | 3,601,269.64 |
| 其中:利息费用 | 3,863,667.71 | 2,519,833.22 | 1,325,300.18 | 5,612,265.45 |
| 其中:利息收入 | 1,682,839.07 | 1,261,644.05 | 714,748.88 | 2,421,000.73 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | - | 11,194,579.02 |
| 资产处置收益 | - | - | - | 287,342.75 |
| 资产减值损失(新) | 1,081,861.33 | 3,358,349.76 | 3,735,993.18 | -18,054,165.47 |
| 信用减值损失(新) | 69,502.93 | -39,528.58 | -47,658.14 | 426,622.77 |
| 其他收益 | 15,774,889.05 | 11,872,051.17 | 6,567,123.44 | 21,278,567.97 |
| 四、营业利润 | 31,845,195.95 | 21,265,622.05 | 4,260,561.38 | -16,965,863.81 |
| 加:营业外收入 | 2,259,824.92 | 2,256,291.15 | 69.69 | 617,920.02 |
| 减:营业外支出 | 588,131.41 | 511,350.83 | 13,704.36 | 810,410.9 |
| 五、利润总额 | 33,516,889.46 | 23,010,562.37 | 4,246,926.71 | -17,158,354.69 |
| 减:所得税费用 | 12,797,164 | 9,842,151.32 | 1,531,549.45 | -13,268,874.08 |
| 六、净利润 | 20,719,725.46 | 13,168,411.05 | 2,715,377.26 | -3,889,480.61 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 20,719,725.46 | 13,168,411.05 | 2,715,377.26 | -3,889,480.61 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 21,117,988.34 | 13,841,586.81 | 2,969,330.7 | 1,497,793.42 |
| 少数股东损益 | -398,262.88 | -673,175.76 | -253,953.44 | -5,387,274.03 |
| 扣除非经常损益后的净利润 | 13,905,948.87 | 7,977,673.71 | 552,547.61 | -17,518,901.65 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.05 | 0.03 | 0.01 | 0 |
| (二)稀释每股收益 | 0.05 | 0.03 | 0.01 | 0 |
| 八、其他综合收益 | 234,158.53 | 761,914.42 | 127,504.82 | -1,086,798.73 |
| 归属于母公司股东的其他综合收益 | 234,158.53 | 761,914.42 | 127,504.82 | -1,086,798.73 |
| 九、综合收益总额 | 20,953,883.99 | 13,930,325.47 | 2,842,882.08 | -4,976,279.34 |
| 归属于母公司股东的综合收益总额 | 21,352,146.87 | 14,603,501.23 | 3,096,835.52 | 410,994.69 |
| 归属于少数股东的综合收益总额 | -398,262.88 | -673,175.76 | -253,953.44 | -5,387,274.03 |
| 公告日期 | 2025-10-31 | 2025-08-22 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |